目的 观察小剂量持续性吸入糖皮质激素对哮喘患儿身高、体重的影响,为哮喘规范治疗提供依据。方法 随机抽取确诊为支气管哮喘的患儿125例,分别在治疗半年、治疗1年、治疗1年半及治疗2年时进行身高、体重测量,测量数据分别与中国城市同年龄健康儿童身高、体重进行比较。结果 患儿身高与中国城市同年龄健康儿童身高、体重进行比较,差异无统计学意义(P>0.05)。结论 小剂量持续性吸入皮质激素并不会影响儿童的生长发育。
Abstract
Objective To observe effects of small doses continuous inhaled corticosteroids on height and weight of the children with asthma,in order to provide the basis for specification of asthma treatment. Methods A total of 125 children with asthma performed the height and weight test for treatment with inhaled corticosteroids at 0.5,1,1.5,2 years.On height and weight in children with asthma was compared with normal children of Chinese city. Result There was no obvious difference on height and weight in children with asthma compared with normal children of Chinese city(P>0.05). Conclusions mall doses of persistent inhaled corticosteroide (ICS) does not affect children's growth.
关键词
糖皮质激素 /
吸入 /
哮喘 /
儿童 /
身高 /
体重
Key words
corticosteroids /
inhale /
asthma /
children /
height /
weight
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] 中华医学会儿科学分会呼吸学组.儿童支气管哮喘诊断与防治指南[J].中华儿科杂志,2008,46(10):745-753.
[2] 江载芳,申昆玲,沈颖.诸福棠实用儿科学[M].8版.北京:人民卫生出版社,2015:61-62.
[3] 全国儿科哮喘协作组.全国90万0~14儿童中支气管患病情况调查[J].中华结核和呼吸杂志,1993,16(Suppl):64-68.
[4] 全国儿童哮喘防治协作组.中国城区儿童哮喘患病率调查[J].中华儿科杂志,2003,41(2):123-127.
[5] 全国儿科哮喘协作组.第三次全国城市儿童哮喘流行病学调查[J].中华儿科杂志,2013,51(10):729-735.
[6] Wong GW,Kwon N,Hong JG.et al.Pediatric asthma control in Asia:phase 2 of asthma insights and reality in Asia-Pacific(AIRIAP2) survey[J].Allergy,2013,68(4):524-530.
[7] 林华宗.皮质激素吸入疗法防治小儿哮喘的进展[J].国外医学·儿科学分册,1999,26(1):15-18.
[8] Papadopoulos NG,Arakawa H,Carlsen KH,et al.International consensus on (ICON) pediatric asthma [J].Allergy,2012,67(8):976-997.
[9] Agertoft L,Pedersen S.Effect of long-term treatment with inhaled budesonide on adult height in children with asthma[J].N Engl J Med,2000,343:1064-1069.
PDF(357 KB)
